128 related articles for article (PubMed ID: 7525023)
1. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain.
Yasuhara O; Aimi Y; McGeer EG; McGeer PL
Brain Res; 1994 Aug; 652(2):346-9. PubMed ID: 7525023
[TBL] [Abstract][Full Text] [Related]
2. Distribution of clusterin in Alzheimer brain tissue.
McGeer PL; Kawamata T; Walker DG
Brain Res; 1992 May; 579(2):337-41. PubMed ID: 1378350
[TBL] [Abstract][Full Text] [Related]
3. Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation.
Conti F; Grude P; Calmus Y; Scoazec JY
J Hepatol; 1997 Nov; 27(5):881-9. PubMed ID: 9382976
[TBL] [Abstract][Full Text] [Related]
4. Role of complement in the aetiology of Pick's disease?
Singhrao SK; Neal JW; Gasque P; Morgan BP; Newman GR
J Neuropathol Exp Neurol; 1996 May; 55(5):578-93. PubMed ID: 8627348
[TBL] [Abstract][Full Text] [Related]
5. Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli.
French LE; Tschopp J; Schifferli JA
Clin Exp Immunol; 1992 Jun; 88(3):389-93. PubMed ID: 1606720
[TBL] [Abstract][Full Text] [Related]
6. Perforant path transection induces complement C9 deposition in hippocampus.
Johnson Sa; Young-Chan CS; Laping NJ; Finch CE
Exp Neurol; 1996 Apr; 138(2):198-205. PubMed ID: 8620918
[TBL] [Abstract][Full Text] [Related]
7. The terminal complement complex is generated in chronic leg ulcers in the absence of protectin (CD59).
Balslev E; Thomsen HK; Danielsen L; Sheller J; Garred P
APMIS; 1999 Nov; 107(11):997-1004. PubMed ID: 10598871
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
Hakulinen J; Meri S
Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
[TBL] [Abstract][Full Text] [Related]
9. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59).
Rautemaa R; Meri S
J Dent Res; 1996 Jan; 75(1):568-74. PubMed ID: 8655761
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease.
Tandon N; Yan SL; Morgan BP; Weetman AP
Immunology; 1994 Apr; 81(4):643-7. PubMed ID: 7518800
[TBL] [Abstract][Full Text] [Related]
12. The expression of complement regulatory proteins by adult human oligodendrocytes.
Scolding NJ; Morgan BP; Compston DA
J Neuroimmunol; 1998 Apr; 84(1):69-75. PubMed ID: 9600710
[TBL] [Abstract][Full Text] [Related]
13. Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex.
Høgåsen K; Mollnes TE; Brandtzaeg P
Infect Immun; 1994 Nov; 62(11):4874-80. PubMed ID: 7523299
[TBL] [Abstract][Full Text] [Related]
14. Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).
Chauhan AK; Moore TL
Clin Exp Immunol; 2006 Sep; 145(3):398-406. PubMed ID: 16907906
[TBL] [Abstract][Full Text] [Related]
15. Cloning of the sixth complement component and, spatial and temporal expression profile of MAC structural and regulatory genes in chicken.
Mikrou A; Zarkadis IK
Dev Comp Immunol; 2010 May; 34(5):485-90. PubMed ID: 20067805
[TBL] [Abstract][Full Text] [Related]
16. Supported Lipid Bilayer Platform To Test Inhibitors of the Membrane Attack Complex: Insights into Biomacromolecular Assembly and Regulation.
Yorulmaz S; Jackman JA; Hunziker W; Cho NJ
Biomacromolecules; 2015 Nov; 16(11):3594-602. PubMed ID: 26444518
[TBL] [Abstract][Full Text] [Related]
17. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
18. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
19. Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin.
French LE; Polla LL; Tschopp J; Schifferli JA
J Invest Dermatol; 1992 May; 98(5):758-63. PubMed ID: 1569324
[TBL] [Abstract][Full Text] [Related]
20. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration.
Johnson LV; Leitner WP; Staples MK; Anderson DH
Exp Eye Res; 2001 Dec; 73(6):887-96. PubMed ID: 11846519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
